📌 RBM42 Identified as a Mediator of Oncogenic mRNA Translation Specificity 🔗 Find More Research Here: pubmed.ai/?utm_source=X&utm_… Context - RNA-binding proteins (RBPs) are crucial for post-transcriptional gene regulation. - Aberrant RBP activity contributes to cancer-specific translation programs. Highlights from the new study - Functional screening pinpointed RBM42 as a key mediator of oncogenic mRNA translation. - RBM42 enhances specificity in translational control, favoring cancer-related transcripts. - Evidence suggests RBM42 helps establish a tumor-supportive proteome. - Findings provide a mechanistic link between RBPs and selective mRNA translation in cancer. Implications - RBM42 may represent a novel therapeutic target for disrupting oncogenic protein synthesis. - Highlights the broader need to map RBP-driven translation networks in oncology. #CancerResearch #RNA #TranslationControl #Oncology #MolecularMechanisms